Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Sage’s postpartum depression treatment Zulresso gains US approval

First approval of its kind

Brain power: fresh approaches to Alzheimer’s drug discovery

New alliances are learning from past mistakes and breaking down research barriers

- PMLiVE

Urovant slips on phase 3 incontinence drug data

Underwhelming results send shares down

- PMLiVE

Roche, AbbVie hit by clinical hold for Venclexta in myeloma

Safety concerns could hit blockbuster expectations

Bristol Myers Squibb logo

BMS defends Celgene buyout ahead of shareholder vote

BMS battles for hearts and minds before shareholder vote

- PMLiVE

Is May’s Brexit deal sinking after Speaker’s procedural torpedo?

Life sciences firms must keep planning for no-deal - for now

- PMLiVE

Apple Watch shows promise in heart study, but doctors sceptical

Study important for Apple's ambitions in healthcare

- PMLiVE

New faces at 11 London, ramarketing and MSL

Latest movers in healthcare comms

- PMLiVE

Genomics integration: can the NHS rise to the challenge?

Experts gather to discuss the UK’s genomic landscape

- PMLiVE

Sanofi gets cardio outcomes claim for Praluent in EU

Data stronger than rival's, could spark a fight back

- PMLiVE

NICE wants to stop saying ‘no’ – but needs pharma’s co-operation

Suggests Orkambi row has undermined confidence in NICE process

Three questions that should anchor your brand strategy

Ensuring the organisation is focused on pursuing the most attractive commercial opportunities

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links